Exogenous addition of a C-xylopyranoside derivative stimulates keratinocyte dermatan sulfate synthesis and promotes migration

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Muto, Jun ^a   Naidu, Nandita Natasha ^a   Yamasaki, Kenshi ^a   Pineau, Nathalie ^b   Breton, Lionel ^b   Gallo, Richard L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b L ORÉAL RECHERCHE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C BETA DEXTRO XYLOPYRANOSIDE 2 HYDROXY PROPANE; DERMATAN SULFATE; PYRANOSIDE; REPIFERMIN; UNCLASSIFIED DRUG; FGF10 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR 10; GLYCOSIDE; GLYCOSYLTRANSFERASE; UDP XYLOSE PROTEIN XYLOSYLTRANSFERASE; UDP XYLOSE-PROTEIN XYLOSYLTRANSFERASE;

ARTICLE; CARBOHYDRATE ANALYSIS; CARBOHYDRATE SYNTHESIS; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; CELL SECRETION; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; KERATINOCYTE; PROTEIN SECRETION; UPREGULATION; WOUND HEALING; ANIMAL; BIOSYNTHESIS; CELL MOTION; CHEMISTRY; CHO CELL; CRICETULUS; CYTOLOGY; HAMSTER; METABOLISM; MUTATION; SECRETION;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CHO CELLS; CRICETINAE; CRICETULUS; CULTURE MEDIA, CONDITIONED; DERMATAN SULFATE; FIBROBLAST GROWTH FACTOR 10; GLYCOSIDES; HUMANS; KERATINOCYTES; MUTATION; PENTOSYLTRANSFERASES;

EID: 80053595907     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025480     Document Type: Article

References (23)

1. Penc SF, Pomahac B, Winkler T, Dorschner RA, Eriksson E, et al. (1998) Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function. J Biol Chem 273: 28116-28121.
2. Taylor KR, Rudisill JA, Gallo RL, (2005) Structural and sequence motifs in dermatan sulfate for promoting fibroblast growth factor-2 (FGF-2) and FGF-7 activity. J Biol Chem 280: 5300-5306.
3. Ashikari S, Habuchi H, Kimata K, (1995) Characterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor. J Biol Chem 270: 29586-29593.
4. Lyon M, Deakin JA, Rahmoune H, Fernig DG, Nakamura T, et al. (1998) Hepatocyte growth factor/scatter factor binds with high affinity to dermatan sulfate. J Biol Chem 273: 271-278.
5. Maccarana M, Casu B, Lindahl U, (1993) Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J Biol Chem 268: 23898-23905.
6. Turnbull JE, Fernig DG, Ke Y, Wilkinson MC, Gallagher JT, (1992) Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J Biol Chem 267: 10337-10341.
7. Trowbridge JM, Rudisill JA, Ron D, Gallo RL, (2002) Dermatan sulfate binds and potentiates activity of keratinocyte growth factor (FGF-7). J Biol Chem 277: 42815-42820.
8. Bechard D, Gentina T, Delehedde M, Scherpereel A, Lyon M, et al. (2001) Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem 276: 48341-48349.
9. Powers CJ, McLeskey SW, Wellstein A, (2000) Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 7: 165-197.
10. Komi-Kuramochi A, Kawano M, Oda Y, Asada M, Suzuki M, et al. (2005) Expression of fibroblast growth factors and their receptors during full-thickness skin wound healing in young and aged mice. J Endocrinol 186: 273-289.
11. Radek KA, Taylor KR, Gallo RL, (2009) FGF-10 and specific structural elements of dermatan sulfate size and sulfation promote maximal keratinocyte migration and cellular proliferation. Wound Repair Regen 17: 118-126.
12. Fritz TA, Lugemwa FN, Sarkar AK, Esko JD, (1994) Biosynthesis of heparan sulfate on beta-D-xylosides depends on aglycone structure. J Biol Chem 269: 300-307.
13. Esko JD, Stewart TE, Taylor WH, (1985) Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc Natl Acad Sci U S A 82: 3197-3201.
14. Lee PH, Trowbridge JM, Taylor KR, Morhenn VB, Gallo RL, (2004) Dermatan sulfate proteoglycan and glycosaminoglycan synthesis is induced in fibroblasts by transfer to a three-dimensional extracellular environment. J Biol Chem 279: 48640-48646.
15. Lawrence R, Olson SK, Steele RE, Wang L, Warrior R, et al. (2008) Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling. J Biol Chem 283: 33674-33684.
16. Lawrence R, Lu H, Rosenberg RD, Esko JD, Zhang L, (2008) Disaccharide structure code for the easy representation of constituent oligosaccharides from glycosaminoglycans. Nat Methods 5: 291-292.
17. Marguerie A, Bajolle F, Zaffran S, Brown NA, Dickson C, et al. (2006) Congenital heart defects in Fgfr2-IIIb and Fgf10 mutant mice. Cardiovasc Res 71: 50-60.
18. Revest JM, Spencer-Dene B, Kerr K, De Moerlooze L, Rosewell I, et al. (2001) Fibroblast growth factor receptor 2-IIIb acts upstream of Shh and Fgf4 and is required for limb bud maintenance but not for the induction of Fgf8, Fgf10, Msx1, or Bmp4. Dev Biol 231: 47-62.
19. Eswarakumar VP, Monsonego-Ornan E, Pines M, Antonopoulou I, Morriss-Kay GM, et al. (2002) The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129: 3783-3793.
20. Revest JM, Suniara RK, Kerr K, Owen JJ, Dickson C, (2001) Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb. J Immunol 167: 1954-1961.
21. Petiot A, Conti FJ, Grose R, Revest JM, Hodivala-Dilke KM, et al. (2003) A crucial role for Fgfr2-IIIb signalling in epidermal development and hair follicle patterning. Development 130: 5493-5501.
22. Sakai S, Onose J, Nakamura H, Toyoda H, Toida T, et al. (2002) Pretreatment procedure for the microdetermination of chondroitin sulfate in plasma and urine. Anal Biochem 302: 169-174.
23. Cha D, O'Brien P, O'Toole EA, Woodley DT, Hudson LG, (1996) Enhanced modulation of keratinocyte motility by transforming growth factor-alpha (TGF-alpha) relative to epidermal growth factor (EGF). J Invest Dermatol 106: 590-597.